CRP and chronic obstructive pulmonary disease: The SUCRA of reducing the CRP in COPD patients in Atorvastatin, Fluvastatin, Rosuvastatin, Pravastatin and Simvastatin were 68.0, 97.7, 49.3, 33.9 and 46.3%, respectively (Table 2 and Fig. 4).